E-LIB Suche - Ergebnisse für: Casado, Antonio

1

Circulating TNF-RII, IP-10 and HGF are associated with seve..:

Carrillo-García, Jaime ; Lacerenza, Serena ; Hindi, Nadia...
Cytokine. 177 (2024) - p. 156542 , 2024

2

European multidisciplinary tumor boards support cross-borde..:

Joneborg, Ulrika ; Bergamini, Alice ; Wallin, Emelie...
International Journal of Gynecologic Cancer. 33 (2023) 10 - p. 1621-1626 , 2023

Link: https://doi.org/10.1136/..

3

Cost-effectiveness of olaparib plus bevacizumab versus beva..:

Cedillo, Sergio ; Garí, Carla ; Aceituno, Susana...
International Journal of Gynecologic Cancer. 34 (2023) 2 - p. 277-284 , 2023

Link: https://doi.org/10.1136/..

4

Efficacy and safety of olaparib according to age in BRCA1/2..:

Trillsch, Fabian ; Mahner, Sven ; Ataseven, Beyhan...
Gynecologic Oncology. 165 (2022) 1 - p. 40-48 , 2022

Link: https://doi.org/10.1016/..

5

A European, Observational, Prospective Trial of Trabectedin..:

Pignata, Sandro ; Scambia, Giovanni ; Villanucci, Alessandro...
The Oncologist. 26 (2021) 4 - p. e658-e668 , 2021

Link: https://doi.org/10.1002/..

6

Inflammatory myofibroblastic tumour of an unusual presentat..:

López de Sa, Alfonso ; Pascual, Alejandro ; Garcia Santos, Javier...
World Journal of Surgical Oncology. 19 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Complete Spontaneous Regression of Lung Metastases after Re..:

Marquina, Gloria ; Sanchez-Ramon, Silvia ; Sarnago, Ana...
Case Reports in Oncology. 14 (2021) 1 - p. 152-159 , 2021

Link: https://doi.org/10.1159/..

8

Practical clinical guidelines of the EOTTD for treatment an..:

Lok, Christianne ; van Trommel, Nienke ; Massuger, Leon...
European Journal of Cancer. 130 (2020) - p. 228-240 , 2020

Link: https://doi.org/10.1016/..

9

Genomic Signatures of Immune Activation Predict Outcome in ..:

Alcaraz-Sanabria, Ana ; Baliu-Piqué, Mariona ; Saiz-Ladera, Cristina...
Frontiers in Oncology. 9 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

10

Are antiangiogenics a good 'partner' for immunotherapy in o..:

García-Martínez, Elena ; Redondo, Andres ; Piulats, Josep Maria..
Angiogenesis. 23 (2020) 4 - p. 543-557 , 2020

Link: https://doi.org/10.1007/..

11

Trabectedin for Reversing Platinum Resistance and Resensiti..:

Casado, Antonio ; Callata, Hector R ; Manzano, Aranzazu...
Future Oncology. 15 (2018) 3 - p. 271-280 , 2018

Link: https://doi.org/10.2217/..

12

Targeted Agents in Cervical Cancer: Beyond Bevacizumab:

Marquina, Gloria ; Manzano, Aranzazu ; Casado, Antonio
Current Oncology Reports. 20 (2018) 5 - p. , 2018

Link: https://doi.org/10.1007/..

13

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway..:

Despierre, Evelyn ; Vergote, Ignace ; Anderson, Ryan...
Targeted Oncology. 11 (2016) 3 - p. 429-429 , 2016

Link: https://doi.org/10.1007/..

14

Standard Versus Continuous Administration of Capecitabine i..:

Martín, Miguel ; Martínez, Noelia ; Ramos, Manuel...
The Oncologist. 20 (2015) 2 - p. 111-112 , 2015

Link: https://doi.org/10.1634/..

15

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers ..:

on behalf of the European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG), Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire (GINECO), Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO), National Cancer Research Institute (NCRI), Australia New Zealand Gynaecological Oncology Group (ANZGOG), and the Mario Negri Gynecologic Oncology group (MaNGO) ; Despierre, Evelyn ; Vergote, Ignace...
Targeted Oncology. 10 (2015) 4 - p. 583-596 , 2015

Link: https://doi.org/10.1007/..